Does PIMAVANSERIN Cause Mobility decreased? 379 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 379 reports of Mobility decreased have been filed in association with PIMAVANSERIN (pimavanserin). This represents 0.8% of all adverse event reports for PIMAVANSERIN.
379
Reports of Mobility decreased with PIMAVANSERIN
0.8%
of all PIMAVANSERIN reports
53
Deaths
84
Hospitalizations
How Dangerous Is Mobility decreased From PIMAVANSERIN?
Of the 379 reports, 53 (14.0%) resulted in death, 84 (22.2%) required hospitalization, and 1 (0.3%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PIMAVANSERIN. However, 379 reports have been filed with the FAERS database.
What Other Side Effects Does PIMAVANSERIN Cause?
Hallucination (10,839)
Death (9,352)
Drug ineffective (5,545)
Product dose omission issue (3,808)
Confusional state (3,779)
Fall (3,366)
Delusion (2,421)
Hallucination, visual (1,954)
Gait disturbance (1,923)
Parkinson's disease (1,918)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which PIMAVANSERIN Alternatives Have Lower Mobility decreased Risk?
PIMAVANSERIN vs PIMECROLIMUS
PIMAVANSERIN vs PIMOZIDE
PIMAVANSERIN vs PINAVERIUM
PIMAVANSERIN vs PINDOLOL
PIMAVANSERIN vs PIOGLITAZONE